Methylphenidate on HealthSpring Assurance Rx (S5617-227)
Covered.
Tier 3 (preferred brand). Quantity limit of 90 per 30 days.
$9.39
Patient pays / month, after deductible
$37.55
Patient pays / month, before the $615.00 deductible
$28.16
Patient pays / 90 days by mail
$0
After the yearly $2,100.00 out-of-pocket cap
METHYLPHENIDATE HYDROCHLORIDE 5 mg Tablet at a preferred retail pharmacy, from the plan's negotiated price of $37.55 for a month. Other covered strengths are listed below.
All 13 covered strengths and forms
| Form | Tier | Patient pays / month | Limits |
|---|---|---|---|
| METHYLPHENIDATE HYDROCHLORIDE 10 mg Tablet | 3 | $9.78 | 90 per 30 days |
| METHYLPHENIDATE HYDROCHLORIDE 10 mg Tablet, Extended Release | 4 | 29% | None |
| METHYLPHENIDATE HYDROCHLORIDE 18 mg Tablet, Extended Release | 4 | 29% | None |
| METHYLPHENIDATE HYDROCHLORIDE 18 mg Tablet, Extended Release | 4 | 29% | None |
| METHYLPHENIDATE HYDROCHLORIDE 20 mg Tablet | 3 | $16.76 | 90 per 30 days |
| METHYLPHENIDATE HYDROCHLORIDE 20 mg Tablet, Extended Release | 4 | 29% | None |
| METHYLPHENIDATE HYDROCHLORIDE 27 mg Tablet, Extended Release | 4 | 29% | None |
| METHYLPHENIDATE HYDROCHLORIDE 36 mg Tablet, Extended Release | 4 | 29% | None |
| METHYLPHENIDATE HYDROCHLORIDE 5 mg Tablet | 3 | $9.39 | 90 per 30 days |
| METHYLPHENIDATE HYDROCHLORIDE 54 mg Tablet, Extended Release | 4 | 29% | None |
| METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE 27 mg Tablet, Extended Release | 4 | 29% | None |
| METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE 36 mg Tablet, Extended Release | 4 | 29% | None |
| METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE 54 mg Tablet, Extended Release | 4 | 29% | None |
Verify with the plan before prescribing or filling. Member services: (800)222-6700. Data from the CMS 2026 Part D formulary and pricing files. Full plan details
Plan ID s5617-227